GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Astellas Pharma Inc (OTCPK:ALPMY) » Definitions » 3-Year Dividend Growth Rate

Astellas Pharma (Astellas Pharma) 3-Year Dividend Growth Rate : 14.50% (As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Astellas Pharma 3-Year Dividend Growth Rate?

Astellas Pharma's Dividends per Share for the three months ended in Dec. 2023 was $0.00.

The historical rank and industry rank for Astellas Pharma's 3-Year Dividend Growth Rate or its related term are showing as below:

ALPMY' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 1.3   Med: 6.3   Max: 52.5
Current: 14.5

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Astellas Pharma was 52.50% per year. The lowest was 1.30% per year. And the median was 6.30% per year.

ALPMY's 3-Year Dividend Growth Rate is ranked better than
64.17% of 321 companies
in the Drug Manufacturers industry
Industry Median: 9.1 vs ALPMY: 14.50

During the past 12 months, Astellas Pharma's average Dividends Per Share Growth Rate was 18.20% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 14.50% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 10.30% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 7.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Astellas Pharma's Dividend Payout Ratio for the three months ended in Dec. 2023 was 0.00. As of today, Astellas Pharma's Dividend Yield % is 4.75%.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Astellas Pharma Inc is 180.56, which seems too high.

Good Sign:

Astellas Pharma Inc stock dividend yield is close to 10-year high.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Astellas Pharma's 3-Year Dividend Growth Rate

For the Drug Manufacturers - General subindustry, Astellas Pharma's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Astellas Pharma's 3-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Astellas Pharma's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Astellas Pharma's 3-Year Dividend Growth Rate falls into.



Astellas Pharma 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Astellas Pharma  (OTCPK:ALPMY) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Astellas Pharma's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0/ 0.055
=0.00

During the past 13 years, the highest Dividend Payout Ratio of Astellas Pharma was 1.11. The lowest was 0.33. And the median was 0.47.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Astellas Pharma Inc is 180.56, which seems too high.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Astellas Pharma Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 0.2362023-09-282023-09-292023-12-18Cash Dividendsemi-annuallyUSD:USD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Astellas Pharma's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=0.236/9.56
=2.47 %

Current Share Price is $9.56.
Astellas Pharma's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.236.

During the past 13 years, the highest Dividend Yield of Astellas Pharma was 4.75%. The lowest was 1.38%. And the median was 2.30%.

Good Sign:

Astellas Pharma Inc stock dividend yield is close to 10-year high.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Astellas Pharma 3-Year Dividend Growth Rate Related Terms>


Astellas Pharma (Astellas Pharma) Business Description

Traded in Other Exchanges
Address
2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8411
Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Royalty income makes up a small percentage of Astellas' overall sales. Its largest therapeutic area by sales composition is oncology, followed by urology and transplantation. The company uses mergers and acquisitions as part of its long-term growth strategy. Astellas enters into strategic partnerships and licensing agreements to strengthen its commercialization platforms.

Astellas Pharma (Astellas Pharma) Headlines

From GuruFocus

Astellas to Acquire Propella Therapeutics

By PRNewswire 11-16-2023